Scotland · NHS Scotland MSAN
Lithium carbonate (Priadel®) 200mg and 400mg modified release tablets
MSAN(2020)88 · Level 3 · issued 03 Sep 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: To be discontinued, supplies are expected to be exhausted by April | Discontinued | — |
| 1. Priadel® (lithium carbonate) 200mg and 400mg modified-release tablets are being discontinued | Discontinued | — |
| 4. Other brands of lithium carbonate tablets remain available including Liskonum ® 450mg | Available | — |
| 13. Essential Pharma will discontinue Priadel® 200mg and 400mg modified-release tablets with | Discontinued | — |
| Priadel® modified-release tablets are being discontinued, there is a need to ensure patients are | Discontinued | — |
| sudden discontinuation of lithium is associated with relapse in up to 50% of patients. Relapse is | Discontinued | — |
| Priadel® Lithium Carbonate 200mg Modified-release tablets Discontinued April 2021 | Discontinued | — |
| Priadel® Lithium Carbonate 400mg Modified-release tablets Discontinued April 2021 | Discontinued | — |
| Essential Pharma* Lithium Carbonate 250mg Film-coated (f/c) tablets Remains Available | Available | — |
| Camcolit® Lithium Carbonate 400mg Modified-release tablets Remains Available | Available | — |
| Liskonum® Lithium Carbonate 450mg Modified-release tablets Remains Available | Available | — |
| Liskonum ®; discontinue Priadel® modified-release tablets and start the alternative brand at a | Discontinued | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.